Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy

Zepbound helped patients lose more weight than a major rival in a head-to-head trial.

Topics

Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial

Zepbound's greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.
CNBC - 10h
Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

New trial data has cemented Club holding Eli Lilly's pole position in the highly competitive weight loss drug race.
CNBC - 2h
Zepbound brings more weight loss than Wegovy: Drugmaker

Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical trial results. Zepound manufacturer Eli Lilly released results from their ...
The Hill - 2h
A rival weight loss drug to Wegovy helped people shed more pounds, study shows

People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical trial, Lilly said in a release Wednesday.
NBC News - 7h
Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance

The health care giant’s David Ricks defended the agency’s role in reviewing data and ensuring drug safety.
The New York Times - 31m
Rival union official says Atlantic City casino union boss should resign for opposing a smoking ban

Workers seeking an end to smoking in Atlantic City casinos say the main employee union has been won over by tobacco companies seeking allies in the fight against smoking restrictions
ABC News - 1d
Experts create controllable gastric balloon to aid weight loss

Device inflates before eating and contracts afterwards, simulating the effects of having a meal, say scientists. From weight loss jabs to vibrating pills , the obesity crisis has spawned myriad ...
The Guardian - 1d

Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy

Topics

Related

Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial

Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

Zepbound brings more weight loss than Wegovy: Drugmaker

A rival weight loss drug to Wegovy helped people shed more pounds, study shows

Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance

Rival union official says Atlantic City casino union boss should resign for opposing a smoking ban

Experts create controllable gastric balloon to aid weight loss

More from MarketWatch

The Dow closes above 45,000 for the first time. It may be time to rethink what makes a milestone.

UnitedHealth executive Brian Thompson killed in ‘targeted attack’ — here’s what we know

Five Below announces new CEO, shares jump on more upbeat outlook

November jobs report may show big gain — but not because more companies are hiring

Inflation threatens Fed rate-cut expectations once again. Here’s why.